{"id":64166,"date":"2025-12-06T13:15:03","date_gmt":"2025-12-06T13:15:03","guid":{"rendered":"https:\/\/crowdfundjunction.com\/blog\/healthcare-stocks-dubbed-the-ultimate-hedge-against-ai-correction\/"},"modified":"2025-12-06T13:15:03","modified_gmt":"2025-12-06T13:15:03","slug":"healthcare-stocks-dubbed-the-ultimate-hedge-against-ai-correction","status":"publish","type":"post","link":"https:\/\/crowdfundjunction.com\/blog\/healthcare-stocks-dubbed-the-ultimate-hedge-against-ai-correction\/","title":{"rendered":"Healthcare stocks dubbed ‘the ultimate hedge’ against AI correction"},"content":{"rendered":"

(Originally posted on : Invezz )<\/b>
\n<\/p>\n

\n

Kepler Cheuvreux head of economics and cross asset strategy, Arnaud Girod, recommends gaining or growing exposure to healthcare stocks if you\u2019re concerned about an AI bubble popping in 2026.<\/p>\n

Experts, including the \u201cBig Short\u201d investor Michael Burry<\/a>, have sounded the alarm on valuations turning overly stretched for artificial intelligence stocks in recent months.<\/p>\n

But healthcare offers \u201cthe exact opposite\u201d to investors heading into the new year, Girod told CNBC<\/em> in an interview today. In fact, the sector may be \u201cthe ultimate hedge\u201d against an AI correction, he added.<\/p>\n

Why are healthcare stocks a hedge against AI correction<\/h2>\n


\n Copy link to section<\/span>
\n <\/a><\/p>\n

According to Arnaud Girod, healthcare firms are structurally insulated from risks of AI disruption.<\/p>\n

Unlike tech firms whose business models hinge on rapid innovation cycles, healthcare franchises are anchored in essential demand and regulatory frameworks.<\/p>\n

On CNBC<\/em>, he recommended that investors seek stocks that \u201cwon\u2019t be challenged by AI disruption\u201d but are capable of leveraging the technology for productivity gains.<\/p>\n

AI is already helping drugmakers streamline clinical trials, reduce costs, and accelerate innovation. This dual dynamic \u2013 protection from disruption and potential efficiency upside \u2013 makes healthcare stocks uniquely positioned as a hedge.<\/p>\n

In a market where artificial intelligence<\/a> drives nearly 40% of US equity performance, healthcare offers stability, resilience, diversification, and durability, Girod noted.<\/p>\n

Girod is particularly bullish on European healthcare stocks<\/h2>\n


\n Copy link to section<\/span>
\n <\/a><\/p>\n

Kepler Cheuvreux is particularly constructive on European healthcare stocks heading into 2026.<\/p>\n

Its senior strategist recently upgraded the EU-based healthcare names to \u201cstrong overweight\u201d \u2013 citing improved visibility for pharmaceutical companies after years of policy and tariff headwinds.<\/p>\n

The firm\u2019s quarterly playbook emphasized that demographic trends such as aging populations and rising obesity rates provide long-term structural support to the European healthcare stocks.<\/p>\n

With tariffs less threatening and drug pricing reforms turning out milder than feared, Girod sees renewed momentum ahead. \u00a0<\/p>\n

A name he\u2019s particularly bullish on is BB Biotech (SWX: BION) \u2013 a specialized vehicle that offers concentrated access to innovative biotech names.<\/p>\n

Kepler recommends BB Biotech for specialized exposure<\/h2>\n


\n Copy link to section<\/span>
\n <\/a><\/p>\n

BB Biotech is a top pick among Kepler Cheuvreux experts due to its disciplined investment model and track record.<\/p>\n

BION targets a 15% annual return by investing globally in fast-growing biotech firms<\/a> developing breakthrough therapies. It allocated up to 10% to private firms as well, enabling early exposure to promising technologies.<\/p>\n

Strengths include its evergreen structure, history of early bets on transformative drugs, and robust due diligence process. A healthy dividend yield of 3.93% makes it even more attractive for income-focused investors.<\/p>\n

According to Arnaud Girod, BION embodies the healthcare sector\u2019s resilience and upside, making it a strategic hedge against AI-driven market turbulence.<\/p>\n

For investors seeking diversification, stability, and long-term growth potential, it represents a compelling opportunity to balance risk while capitalizing on innovation.<\/p>\n<\/p><\/div>\n

Source link <\/a>
\n
<\/p>\n","protected":false},"excerpt":{"rendered":"

(Originally posted on : Invezz ) Kepler Cheuvreux head of economics and cross asset strategy, Arnaud Girod, recommends gaining or growing exposure to healthcare stocks if you\u2019re concerned about an AI bubble popping in 2026. Experts, including the \u201cBig Short\u201d investor Michael Burry, have sounded the alarm on valuations turning overly stretched for artificial intelligence […]<\/p>\n","protected":false},"author":30,"featured_media":64167,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[38],"tags":[],"_links":{"self":[{"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/posts\/64166"}],"collection":[{"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/comments?post=64166"}],"version-history":[{"count":0,"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/posts\/64166\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/media\/64167"}],"wp:attachment":[{"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/media?parent=64166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/categories?post=64166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crowdfundjunction.com\/blog\/wp-json\/wp\/v2\/tags?post=64166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}